Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Immuno-oncology

UNSW & Garvan Institute Take Precision Medicine Revolution to War Against Pancreatic Cancer in Australia

Thanks to an $3.75 million grant injection from the Cancer Institute, NSW Translational Program, researchers and clinicians from UNSW and […]

UNSW & Garvan Institute Take Precision Medicine Revolution to War Against Pancreatic Cancer in Australia
1 week ago
Share

Erasmus MC Spin-off Secures Seeding Funding in Rotterdam to Develop Life-Saving T-cell Therapies for Solid Tumors

An Erasmus MC biotech venture spin-off was announced recently in Rotterdam, Netherlands. Pan Cancer T B.V., founded by Prof. Dr. […]

Erasmus MC Spin-off Secures Seeding Funding in Rotterdam to Develop Life-Saving T-cell Therapies for Solid Tumors
4 weeks ago
Share

FDA Grants Orphan Drug Designation to BCMA-targeting Specific T Cell Activating Recombinant Protein (HPN217) for Patients with Multiple Myeloma

The U.S. Food and Drug Administration decided to open the Orphan Drug Designation (ODD) to an investigational drug for the […]

FDA Grants Orphan Drug Designation to BCMA-targeting Specific T Cell Activating Recombinant Protein (HPN217) for Patients with Multiple Myeloma
1 month ago
Share

University of Copenhagen Spin-out Raises $154m Targeting Novel Immune-Modulating Anti-Cancer Therapies

IO Biotech, a Danish clinical-stage biotech venture developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology raised EUR […]

University of Copenhagen Spin-out Raises $154m Targeting Novel Immune-Modulating Anti-Cancer Therapies
2 months ago
Share

University of Louisville’s Brown Cancer Center Embraces Immuno-Oncology Developed at NCI: Some Patients See Dramatic Results

A 46 year-old man residing in the Louisville, Kentucky area was given about six months to live, according to a […]

University of Louisville Brown Cancer Center Embraces Immuno-Oncology Developed at NCI Some Patients See Dramatic Results
4 months ago
Share

Sanofi Spends $360m to Accelerate Cell Therapy Drugs for Oncology & Infectious Disease

French pharmaceutical giant Sanofi has made an offer to acquire Kiadis, a clinical-stage biotech company developing what they refer to […]

Sanofi Spends $360m to Accelerate Cell Therapy Drugs for Oncology & Infectious Disease
4 months ago
Share

French Biotech Pursues T-Cell Based Vaccines Targeting COVID-19—No Possible Commercialization Until 2022

Ose Immunotherapeutics will conduct a clinical trial involving up to 400 patients for an experimental COVID-19 vaccine it hopes can […]

French Biotech Pursues T-Cell Based Vaccines Targeting COVID-19—No Possible Commercialization Until 2022
5 months ago
Share

CHOP Cancer Researchers Turn Attention to COVID-19 & Identify Potential Vaccine Targets

Cancer researchers at Children’s Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify […]

CHOP Cancer Researchers Turn Attention to COVID-19 & Identify Potential Vaccine Targets
9 months ago
Share

Promising Interim Results for Investigational Combination Therapies Treating Newly Diagnosed Glioblastoma

The diagnosis of Glioblastoma, an aggressive tumor of the central nervous system, changes life as we know it. Upon the initial […]

Promising Interim Results for Investigational Combination Therapies Treating Newly Diagnosed Glioblastoma
10 months ago
Share

Three Research Sites to Lead Clinical Trial of I-Mab’s of TJM2 to Counter COVID-19’s Deadly Cytokine Storm

Shanghai-based I-Mab was cleared by the U.S. Food and Drug Administration to conduct a Phase I clinical trial to assess […]

Three Research Sites to Lead Clinical Trial of I-Mab’s of TJM2 to Counter COVID-19’s Deadly Cytokine Storm
11 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.